-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Aliskiren is a pharmaceutical drug used for the treatment of hypertension and congestive heart failure.
In the chemical industry, it is commonly referred to as the "novel tyrosine kinase inhibitor" and is used in the production of various types of medication, including anticancer drugs and immunosuppressive agents.
The production of aliskiren inter-11 involves a series of carefully controlled chemical reactions, each of which must be carried out with precision to ensure the purity and potency of the final product.
The manufacturing process involves several steps, including the synthesis of the basic chemical structure, the modification of that structure to create the active ingredient, and the purification and packaging of the final product.
The synthesis of the basic chemical structure of aliskiren inter-11 involves the use of various organic compounds, including acetyl chloride, acetic anhydride, and lithium.
These compounds are combined in a series of reactions that result in the formation of the basic structure of the drug.
This process requires the use of specialized equipment and the careful control of reaction conditions to ensure the desired product is produced.
Once the basic structure of aliskiren inter-11 has been synthesized, it is modified to create the active ingredient.
This involves the addition of certain chemical groups to the molecule, which enhance its ability to target specific cells and tissues in the body.
This process is carried out using a variety of reagents, including triethylamine, N,N-dimethylformamide, and hydrochloric acid.
After the active ingredient has been synthesized, it must be purified and packaged for distribution.
This involves the use of various techniques, including chromatography and filtration, to remove any impurities and ensure the purity of the final product.
The purified aliskiren inter-11 is then packaged in appropriate containers, such as vials or bottles, and labeled with the appropriate information for distribution to pharmacies and medical facilities.
In conclusion, the production of aliskiren inter-11 is a complex process that involves the use of a variety of chemical reactions and techniques.
The careful control of reaction conditions and purification processes is necessary to ensure the purity and potency of the final product, which is used in the treatment of hypertension and congestive heart failure.